Genmab A/S GMAB
55.26 USD +0.34 +0.61%
As of Nov 3, 2:43 PM ET
23.62 52-week range 59.97
- YTD
- +79.40%
- 1 year
- +92.46%
- Open
- 55.45
- Prev close
- 54.92
- Mkt cap
- 33.97B
- Vol
- 1.93M
- Avg vol
- 3.99M
- EPS
- 1.27
- P/E
- 43.50
- Div yield
- 0.00%
More statistics
- Low
- 55.18
- High
- 56.50
- Forward P/E
- 34.76
- Beta
- 0.55
- Short ratio
- 1.67
- Inst. own
- 20.53%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 37.12
- 200-d avg
- 30.50
- 1y target
- 64.65
MAX chart
Chart tools
Chart is warming up
The all-time price history for GMAB has not been loaded yet. Try again in a moment.
Altman Z-Score
21.92 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 2
- Return on Equity 4
- Return on Assets 4
- Debt / Equity 1
- P/E 2
- P/B 3
P/E 19.9×
P/S 5.1×
P/B 3.3×
P/FCF 16.6×
EV/EBITDA 17.1×
EV/Sales 6.1×
FCF Yield 6.0%
Gross Margin 91.7%
Operating Margin 33.6%
Net Margin 25.9%
ROE 16.5%
ROIC 8.5%
ROA 7.5%
Revenue -82.7%
Operating Income -81.3%
EPS (diluted) -87.3%
Free Cash Flow -84.8%
Current Ratio 2.0×
Quick Ratio 2.0×
Debt / Equity 0.9×
Net Debt / EBITDA 2.8×
Interest Coverage 20.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31